Table 2 Gait parameters in healthy controls and patients with INPH.
 | Healthy controls | Patients with INPH | |
---|---|---|---|
Before CSF tap | 24 hours after tap | ||
Velocity, cm/s | 99.12 ± 10.37 | 55.12 ± 4.81c | 67.84 ± 5.01e |
Cadence, steps/min | 110.16 ± 8.81 | 105.33 ± 3.56 | 112.99 ± 3.40d |
Stride length, cm | 109.12 ± 4.74 | 62.76 ± 5.14c | 72.38 ± 5.11d |
Step width, cm | 7.99 ± 0.75 | 13.57 ± 0.57c | 12.90 ± 0.60d |
Toe in/out, ° | 8.69 ± 1.61 | 15.28 ± 1.65b | 14.57 ± 1.51 |
Stride time, s | 1.09 ± 0.04 | 1.17 ± 0.04 | 1.09 ± 0.04d |
Stance phase, % | 62.79 ± 0.69 | 67.81 ± 0.59c | 67.28 ± 0.93 |
Swing phase, % | 37.25 ± 0.69 | 32.19 ± 0.59c | 32.71 ± 0.93 |
Double-limb support phase, % | 25.61 ± 1.56 | 36.49 ± 1.34c | 34.81 ± 1.90 |
CV of stride time, % | 4.34 ± 2.04 | 10.47 ± 2.27a | 6.05 ± 0.79d |
CV of stride length, % | 5.10 ± 1.78 | 14.35 ± 1.98c | 9.44 ± 0.82e |